Chronic anaemia, hyperbaric oxygen and tumour radiosensitivity

Area of Science:

• Oncology
• Radiation Oncology
• Hematology

Background:

• Anemia significantly impacts tumor response to radiotherapy.
• Treatment conditions, such as air versus high-pressure oxygen (HPO), influence radiotherapy outcomes.

Purpose of the Study:

• To investigate the relationship between anemia and tumor response to radiation.
• To evaluate the efficacy of high-pressure oxygen (HPO) in overcoming radiation resistance in anemic tumors.

Main Methods:

• Chronic anemia was induced in C3H mice with mammary adenocarcinoma using a low-iron diet.
• Tumor response to radiation was assessed using a growth delay assay under air or HPO conditions.
• Physiological changes associated with anemia, including hematocrit and blood viscosity, were measured.

Main Results:

• Anemia led to decreased tumor radiosensitivity when radiation was delivered in air.
• High-pressure oxygen (HPO) successfully mitigated the increased radioresistance observed in anemic mice.
• Anemia was associated with increased tumor volume doubling time and a right shift in the oxyhemoglobin dissociation curve.

Conclusions:

• Anemia increases tumor hypoxia, leading to radioresistance.
• High-pressure oxygen (HPO) therapy is effective in overcoming anemia-induced radioresistance.
• Host physiological changes in anemia may contribute to HPO benefits but are insufficient to maintain tumor oxygenation in air.